Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Cannara Biotech Inc
V.LOVE
Alternate Symbol(s):
LOVFF
Healthcare
Cannabis
Cannabis
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers....
In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSXV:LOVE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(1731)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Feb 04, 2026 9:28pm
Mathieu Martin discussion
11.30 mark Mathieu Martin, CFAMathieu Martin, CFA • 3rd+3rd+ MicroCap Expert | Portfolio Manager Newsletter Writer I help you invest in small public companiesMicroCap
...more
(9)
•••
Comeonbiglou
X
Post by
Comeonbiglou
on Feb 04, 2026 1:46pm
Nice Price on the NBPP - $ 2.10
Wow, it seems like a real vote of confidence in order to invest at levels above the current stock price, and at these price levels ($ 2.10). Good Luck to All Longs
(128)
•••
WolfOakville
X
Post by
WolfOakville
on Jan 27, 2026 10:49am
Q1 FINS Review (3.5 / 5 stars) *Downgraded*
"... am I starting to re-think this sector all together?" https://www.wolfofoakville.com/p/cannara-biotech-lovev-fins-review-b86
(1731)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Dec 16, 2025 5:58pm
Mathieu Martin comment takeover implications
Mathieu Martin, CFAMathieu Martin, CFA • 3rd+3rd+ MicroCap Expert | Portfolio Manager Newsletter Writer I help you invest in small public companiesMicroCap Expert | Portfolio Manager
...more
(0)
•••
Flymore123
X
Post by
Flymore123
on Dec 10, 2025 12:44pm
Spéculations intéressante dans un nouveau centre de traiteme
Un nouveau centre de traitement (processing facility) n’est pas seulement un CAPEX.. C’est aussi une arme d’efficacit oprationnelle, qui va rduire les cots? Automatiser peut tre certaines des
...more
(0)
•••
Flymore123
X
Post by
Flymore123
on Dec 04, 2025 11:35am
Little detail from Q4 & 2025 Earnings Présentation.
https://www.cannara.ca/investors/ In my opinion, the wize investor should also go to 15.40 min of the Krivorot/Sosiak presentation and listen to the Total sales number realised in october (after Q4
...more
(0)
•••
Flymore123
X
Post by
Flymore123
on Nov 26, 2025 10:34am
Les vapes Cannara (Tribal / Nugz) sont EN VENTE à la SQDC
Selon Chat Chat.. EXTRAORDINAIRE NOUVELLE. Le catalyseur que nous attendions depuis des mois est maintenant OFFICIELLEMENT ACTIV : Les vapes Cannara (Tribal / Nugz) sont EN VENTE la SQDC ds
...more
(128)
•••
WolfOakville
X
Post by
WolfOakville
on Nov 25, 2025 11:18am
2025 Q4 & Annuals FINS Review (3.75 / 5)
"Cannara Biotech has now had TWENTY consecutive quarters with year over year growth topping 20%." Click for full review
(0)
•••
Flymore123
X
Post by
Flymore123
on Nov 24, 2025 11:44am
Encore selon Chat Chat..
2. Le march n’intgre pas correctement cet actif La plupart des investisseurs : ne connaissent pas l’historique de Valleyfield, ne savent pas ce qu’elle a rellement cot
...more
(0)
•••
Flymore123
X
Post by
Flymore123
on Nov 24, 2025 11:40am
Selon Chat Chat..
1. Cannara possde un actif de 350 M$ pour seulement 27 M$ a veut dire : Ils ont pay 8 % du vrai cot de construction (27 M$ ÷ 350 M$ ≈ 0,077) Leur bilan contient un actif
...more
(0)
•••
Flymore123
X
Post by
Flymore123
on Nov 24, 2025 10:10am
Q4 2025 +IA
Congrat Cannara Management team for Q4 and Fiscal 2025. I would suggest to the WISE investor to put this morning's PR Q4 and fiscal 2025+ the 3 grow rooms (33m for 3m in expense) in their IA
...more
(1731)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Nov 15, 2025 8:47pm
Mathieu Martin - Stocks and Stones Substack
My Top Pick: Cannara Biotech (TSX-V: LOVE) To learn more, you can listen to this recent fireside chat I did with Nicholas Sosiak, Cannara’s CFO: My major foray into
...more
(1731)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Nov 05, 2025 2:05pm
Mathieu Martin - Planet Microcap Fireside Chat
Mathieu Martin, CFAMathieu Martin, CFA • 3rd+3rd+ MicroCap Expert | Portfolio Manager Newsletter Writer I help you invest in small public companiesMicroCap Expert | Portfolio Manager
...more
(1731)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Oct 10, 2025 8:17pm
Planet Microcap Toronto
11:00-11:30 AM October 22 Cannara Biotech Inc. (TSX-V: LOVE) Fireside Chat with with Mathieu Martin, Portfolio Manager at Rivemont MicroCap Fund One of his holdings.
(128)
•••
WolfOakville
X
Post by
WolfOakville
on Aug 13, 2025 9:36am
FINS Review (3/75 / 5 stars) & Seal of Approval Pick
"The revenue, margin and expense conversion performance, awards them the rare Wolf Trifecta" Click for Full Review
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Podcasts